" /> PhenX - gastroesophageal reflux disease (GERD) symptoms protocol 191101:-:Pt: Patient:-:PhenX - CISMeF





Preferred Label : PhenX - gastroesophageal reflux disease (GERD) symptoms protocol 191101:-:Pt: Patient:-:PhenX;

LOINC status : TRIAL;

LOINC long common name : PhenX - gastroesophageal reflux disease (GERD) symptoms protocol 191101;

LOINC short name : GERD symptoms proto;

LOINC description : The Gastroesophageal Reflux Disease Questionnaire (GerdQ) is a 6-item questionnaire that helps identify patients with gastroesophageal reflux disease (GERD). Patients are asked to report frequency of symptoms over the past 7 days. If the administration of the GerdQ produces a positive score for GERD, the Gastrointestinal Working Group (WG) recommends performing a pH impedence test to confirm the results and determine disease severity. Please see the Gastrointestinal WG Supplemental Information for a pH impedence test protocol. The Gastroesophageal Reflux Disease Questionnaire (GerdQ) is a proprietary instrument that is available for use with permission from AstraZeneca. To obtain permission, contact AstraZeneca at PROinformation@astrazeneca.com and complete a License Agreement.;

Details


You can consult :


Nous contacter.
28/04/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.